Delivery Order SPE2DR25D3108-SPE2DR26F1PTW
- Not listed
- The Defense Logistics Agency awarded a $9,251.06 delivery order to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 ml pen injectors on September 17, 2025, with completion scheduled for September 18, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical product will be...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,088.36 to AmerisourceBergen Drug Corp for the supply of Mounjaro 12.5 mg/0.5 mL pen auto-injectors on August 12, 2025. This competitively awarded, firm fixed-price delivery order reflects a single shipment transaction under the company's larger indefinite delivery contract with DLA. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor supporting federal medical...
- The Defense Logistics Agency awarded a $56,137.83 delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The product will be delivered to AmerisourceBergen's corporate headquarters...
- The Defense Logistics Agency awarded a $2,041.56 firm fixed price delivery order to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 ml pen auto-injector medication on October 22, 2025, with an ultimate completion date of October 23, 2025. The contract, which carries no set-aside designation, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $2,558.01 firm fixed price delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen auto-injectors on August 7, 2025, with an ultimate completion date of August 8, 2025. This non-set-aside contract represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical product will be delivered to...
- The Defense Logistics Agency awarded a $21,011.11 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Mounjaro 10 mg/0.5 ml pen injectors, with a completion date of September 9, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a single delivery order under AmerisourceBergen's larger indefinite delivery vehicle with DLA Troop Support Medical. The order will be fulfilled from the company's facility in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,472.20 to AmerisourceBergen Drug Corp for the supply of Mounjaro 10 mg/0.5 mL pen auto-injectors on September 5, 2025. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $26,637.01 on December 1, 2025, for the supply of Mounjaro 5 mg/0.5 ml pen injectors. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of December 2, 2025. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency awarded a $1,632.54 delivery order to AmerisourceBergen Drug Corp on May 20, 2025, for the supply of Mounjaro 10 mg/0.5 ml pen injectors. This is a firm fixed-price contract with an ultimate completion date of May 21, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract involves no set-aside designation and was competitively awarded. Performance will occur at...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,162.70 for Mounjaro 7.5 mg/0.5 ml pen auto-injectors on July 23, 2025, with completion targeted for July 24, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be fulfilled at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used for glycemic control, representing part of the company's...
- SPE2DR25D3108Indefinite Delivery Contract
- SPE2DR25D3108-SPE2DR26F1PTWDelivery Order
The Defense Logistics Agency awarded a $1,053.68 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 mL pen auto-injectors on December 4, 2025, with completion targeted for December 5, 2025. This delivery order represents a child contract under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was utilized for this competitive award, consistent with AmerisourceBergen's typical procurement approach through the DLA. This delivery order supports federal medical supply requirements for military and veteran healthcare systems through AmerisourceBergen's comprehensive pharmaceutical distribution capabilities. Mounjaro (tirzepatide), a diabetes medication, represents one of several therapeutic categories the company supplies under its prime vendor agreement with DLA. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen maintains the infrastructure and regulatory compliance necessary to deliver medications across multiple therapeutic domains, including specialty pharmaceuticals and vaccines, to support Defense Health Agency operations and other federal healthcare customers worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 12/3/25 |